ALS Research Reaches Turning Point With Gene Targeted Treatment
For decades, a diagnosis of amyotrophic lateral sclerosis has carried with it an almost unbearable certainty. Patients and families are told to prepare for relentless decline, loss of independence, and a future measured not in years, but often in months. Treatments approved over the years have offered only modest extensions of life, with effects so …